Last deal

Amount

Series B

Stage

26.02.2024

Date

10

all rounds

$46.8M

Total amount

General

About Company
Cyrus Biotechnology creates software tools to speed up basic research in biotech, pharma, and industrial biotechnology.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Cyrus

founded date

01.01.2014

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Cyrus Bench is an enterprise version of the Rosetta molecular modeling and design toolkit that offers an array of bio-molecular computation tools. The company's software provides a portal for protein structure prediction, modeling, stabilization, engineering, and design to accelerate the discovery of biology and small molecules. Cyrus Biotechnology is partnering with leading biotech and pharma companies and research institutes to bring collaborative programs forward from discovery to the clinic. They are based in Seattle, WA, and have worked with over 90 industry partners.
Contacts

Social url